- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Paracetamol syrup sales suspended in Gambia over death of dozens of young children
The children suffered symptoms including an inability to pass urine, fever and vomiting that quickly led to kidney failure.
Banjul: Gambia on Tuesday ordered importers and shops to suspend sales of all brands of paracetamol syrup while the government investigates a suspected link between the medicine and the deaths of dozens of young children.
Last Thursday, the head of the West African country's health service said it had launched the probe after a spike in cases of acute kidney injury among children under the age of five was detected in late July.
The medicines regulator, known as the Medicines Control Agency (MCA), said there was insufficient data to warrant a general ban on paracetamol syrups, a painkiller often used to treat fevers in children.
The children suffered symptoms including an inability to pass urine, fever and vomiting that quickly led to kidney failure.
It did not name any specific brands, but said some samples had been sent abroad for quality control testing.
Last week, World Health Organisation officials said the evidence pointed not to paracetamol but to an infectious origin such as polluted water, but emphasised there were many unanswered questions
Read also: Gambia probes suspected paracetamol syrup link to dozens of child deaths
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751